Analysts’ Weekly Ratings Changes for Waters (WAT)

Waters (NYSE: WAT) has recently received a number of price target changes and ratings updates:

  • 11/4/2026 – Waters had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $535.00 price target on the stock.
  • 11/4/2026 – Waters was given a new $470.00 price target by Stifel Nicolaus.
  • 11/4/2026 – Waters had its price target raised by Citigroup from $470.00 to $536.00. They now have a “buy” rating on the stock.
  • 11/4/2026 – Waters had its price target raised by JPMorgan Chase & Co. from $435.00 to $470.00. They now have a “neutral” rating on the stock.
  • 11/4/2026 – Waters had its price target raised by TD Cowen from $515.00 to $530.00. They now have a “buy” rating on the stock.
  • 11/4/2026 – Waters had its price target raised by Barclays from $500.00 to $530.00. They now have an “overweight” rating on the stock.
  • 11/4/2026 – Waters had its price target raised by Royal Bank Of Canada from $475.00 to $525.00. They now have an “outperform” rating on the stock.
  • 11/4/2026 – Waters had its price target raised by KeyCorp from $460.00 to $500.00. They now have an “overweight” rating on the stock.
  • 10/26/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/18/2026 – Waters was downgraded by Wall Street Zen from “buy” to “hold”.
  • 10/15/2026 – Waters had its price target raised by Deutsche Bank Aktiengesellschaft from $400.00 to $440.00.
  • 10/14/2026 – Waters had its price target raised by JPMorgan Chase & Co. from $400.00 to $435.00.
  • 10/13/2026 – Waters had its price target raised by TD Cowen from $475.00 to $515.00. They now have a “buy” rating on the stock.
  • 10/10/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/8/2026 – Waters was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 10/8/2026 – Waters had its price target raised by Robert W. Baird from $456.00 to $495.00. They now have an “outperform” rating on the stock.
  • 10/7/2026 – Waters had its price target raised by Barclays from $460.00 to $500.00. They now have an “overweight” rating on the stock.
  • 10/7/2026 – Waters had its price target raised by Evercore from $410.00 to $480.00.
  • 10/1/2026 – Waters had its price target raised by Guggenheim from $440.00 to $490.00. They now have a “buy” rating on the stock.
  • 9/21/2026 – Waters had its price target raised by The Goldman Sachs Group from $465.00 to $515.00. They now have a “buy” rating on the stock.

Waters Stock Performance

WAT traded up $0.81 on Wednesday, reaching $476.33. The company had a trading volume of 109,622 shares, compared to its average volume of 966,442. Waters Corporation has a fifty-two week low of $282.77 and a fifty-two week high of $483.33. The stock has a market cap of $46.80 billion, a P/E ratio of 204.44, a P/E/G ratio of 2.71 and a beta of 1.16. The company’s fifty day moving average is $437.19 and its 200 day moving average is $373.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.40 and a current ratio of 0.66.

Waters (NYSE:WAT – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The firm had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.75 billion. During the same period last year, the business posted $3.40 earnings per share. The business’s revenue for the quarter was up 120.9% compared to the same quarter last year. As a group, analysts predict that Waters Corporation will post 14.65 earnings per share for the current fiscal year.

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Further Reading

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.